Australia Stock Exchange release from AVECHO BIOTECHNO : Positive results from AVE's topical CBD pain study
28/03/2022 23:22
Australia Stock Exchange release from AVECHO BIOTECHNO AVE.AX : Positive results from AVE's topical CBD pain study
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement